Efficacy and tolerability of darunavir/ritonavir in combination with abacavir/lamivudine: an option in selected HIV-infected patients.

@article{Santos2013EfficacyAT,
  title={Efficacy and tolerability of darunavir/ritonavir in combination with abacavir/lamivudine: an option in selected HIV-infected patients.},
  author={Ignacio de los Santos and Ana G{\'o}mez-Berrocal and Eulalia Valencia and Victor Asensi and Paloma Gij{\'o}n and Victoria Moreno and Jorge Vergas and Ignacio Bernardino},
  journal={HIV clinical trials},
  year={2013},
  volume={14 5},
  pages={254-9}
}
OBJECTIVE To evaluate the safety and efficacy of abacavir/lamivudine (ABC/3TC) plus darunavir/ritonavir (DRV-RTV) in experienced patients. METHODS The study was conducted in Spain in 6 hospital clinics and involved HIV-positive patients who needed to change their antiretroviral treatment (ART) for several reasons. They started fixed-dose combination (FDC… CONTINUE READING